Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study
Blood Cancer Journal, Published online: 04 December 2019; doi:10.1038/s41408-019-0260-2Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study
Source: Blood Cancer Journal - Category: Hematology Authors: Marinus van Oers Lukas Smolej Mario Petrini Fritz Offner Sebastian Grosicki Mark-David Levin Jaclyn Davis Hiya Banerjee Tommaso Stefanelli Petra Hoever Christian Geisler Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Study